The constellation of family and personal history, the examination and imaging findings suggested a diagnosis of Emery-Dreifuss muscular dystrophy (EDMD). Following genetic counselling, the patient underwent testing of the EDMD gene, which encodes the muscle-specific emerin protein. Sanger sequencing revealed a hemizygous p.Ser52AlafsTer13/c.153delC mutation ( Figure 1D ), resulting in a premature truncation of the protein [2] .
As the atrial electrical silence is frequently observed in EDMD, ablation was not the therapeutic option for our patient. The patient was referred for pacemaker implantation. After right ventricular lead placement electrical cardioversion of AF restored slow sinus rhythm temporarily and the patient was given permanent dual chamber pacemaker. Anticoagulation therapy was administered to prevent thromboembolic events, based on assessment of stroke risk in EDMD patients, the presence of hypertension and the patient's choice [3, 4] .
Genetic studies of his mother, mother's sister and a male cousin showed hemizygous mutation suggesting the EDMD diagnosis in the cousin and revealed that both females were heterozygous carriers ( Figure 1D ). On family assessment patient's male cousin, aged 20, revealed joint contractures, mild limb muscle atrophy and bradyarrhythmias while both female relatives were asymptomatic.
EDMD is a condition characterized by the clinical triad of early-onset contractures, progressive weakness/wasting in humeroperoneal muscles, and cardiac disease with conduction defects, arrhythmia and cardiomyopathy [2] . The disease has X-linked recessive-inheritance and thus typically affects males (cardiac disease may be manifested by some carrier females as well).
Due to the specific clinical manifestation (including muscle atrophy), EDMD could be categorised into group 2 ("Arrhythmias in specific clinical settings") and subgroup O ("Other") of RACDRAs classification (RCDD code:VI-2O) [5] .
Our case shows that atrial arrythmias may be the first clinical manifestation of EDMD.
Appropriate clinical assessment with taking into account family history, serum levels of musclespecific biomarkers and genetic testing may help to establish the primary cause. 
